Prognosis of unexpected and expected pathologic n1 non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 96, Issue 3, 2013, Pages 969-976

  Shin, Sumin ^a   Kim, Hong Kwan ^a   Choi, Yong Soo ^a   Kim, Kwhanmien ^b   Kim, Jhingook ^a   Shim, Young Mog ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORACOTOMY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

10;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84883227887     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.04.070     Document Type: Conference Paper

References (20)

1. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
2. V.W. Rusch, J. Crowley, and D.J. Giroux The IASLC Lung Cancer Staging Project: proposals for the revision of the descriptors in the forthcoming seventh edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 603 612
3. A. Bille, E. Pelosi, and A. Skanjeti Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography Eur J Cardiothorac Surg 36 2009 440 445
4. S. Watanabe, H. Asamura, K. Suzuki, and R. Tsuchiya Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer Ann Thorac Surg 79 2005 1682 1685
5. T. Hishida, J. Yoshida, M. Nishimura, Y. Nishiwaki, and K. Nagai Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer Thorax 63 2008 526 531
6. N.C. Gupta, G.M. Graeber, and H.A. Bishop Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions Chest 117 2000 773 778
7. Y.N. Kim, C.A. Yi, and K.S. Lee A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer Eur Radiol 22 2012 1537 1546
8. R.J. Cerfolio, and A.S. Bryant Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer Ann Thorac Surg 84 2007 182 188 discussion 9-90
9. H.K. Park, K. Jeon, and W.J. Koh Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT Respirology 15 2010 1179 1184
10. G.A. Silvestri, M.K. Gould, and M.L. Margolis Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition) Chest 132 2007 178S 201S
11. F.C. Detterbeck, M.A. Jantz, M. Wallace, J. Vansteenkiste, and G.A. Silvestri Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 202S 220S
12. Y.S. Choi, Y.M. Shim, J. Kim, and K. Kim Mediastinoscopy in patients with clinical stage I non-small cell lung cancer Ann Thorac Surg 75 2003 364 366
13. A. Ernst, R. Eberhardt, M. Krasnik, and F.J. Herth Efficacy of endobronchial ultrasound-guided transbronchial needle aspiration of hilar lymph nodes for diagnosing and staging cancer J Thorac Oncol 4 2009 947 950
14. S.A. Carrillo, V.C. Daniel, N. Hall, C.L. Hitchcock, P. Ross Jr., and E.S. Kassis Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer Ann Thorac Surg 93 2012 1621 1624
15. H.K. Kim, Y.S. Choi, and K. Kim Outcomes of mediastinoscopy and surgery with or without neoadjuvant therapy in patients with non-small cell lung cancer who are N2 negative on positron emission tomography and computed tomography J Thorac Oncol 6 2011 336 342
16. N. Al-Sarraf, R. Aziz, and K. Gately Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography Eur J Cardiothorac Surg 33 2008 104 109
17. T. Fusimoto, S.D. Cassivi, and Ping Yang Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival J Thorac Cardiovasc Surg 132 2006 499 506
18. J.M. Varlotto, A. Recht, J.C. Flickinger, L.N. Medford-Davis, A.M. Dyer, and M.M. Decamp Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer Cancer 115 2009 1059 1069
19. J.Y. Douillard, R. Rosell, and M. De Lena Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 2006 719 727
20. C.A. Butts, K. Ding, and L. Seymour Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10 J Clin Oncol 28 2010 29 34